Drug information provided by: Merative, Micromedex®
Trifluridine and tipiracil combination is used alone or in combination with bevacizumab to treat metastatic colorectal cancer (cancer of the colon or rectum that has spread to other parts of the body) in patients who have received other cancer medicines (eg, fluoropyrimidine, oxaliplatin, irinotecan).
Trifluridine and tipiracil combination is also used to treat metastatic gastric or gastroesophageal junction adenocarcinoma (stomach cancer that has spread) that has been previously treated with at least 2 other cancer treatments (eg, fluoropyrimidine, irinotecan, HER2/neu-targeted therapy, platinum medicine, taxane medicine).
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: Aug. 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.